about
The CD8 T-cell response during tolerance induction in liver transplantationELISA-Based Crossmatching Allowing the Detection of Emerging Donor-Specific Anti-HLA Antibodies through the Use of Stored Donors' Cell Lysates.Sensitive solid-phase detection of donor-specific antibodies as an aid highly relevant to improving allograft outcomes.Artificially Positive Crossmatches Not Leading to the Refusal of Kidney Donations due to the Usage of Adequate Diagnostic ToolsPathogenesis of chronic allograft rejection.Novel solid phase-based ELISA assays contribute to an improved detection of anti-HLA antibodies and to an increased reliability of pre- and post-transplant crossmatching.Chronic inflammation of the placenta: definition, classification, pathogenesis, and clinical significance.Immunosuppressive properties of mesenchymal stem cells.Transplant immunology for non-immunologist.Methodological aspects of anti-human leukocyte antigen antibody analysis in solid organ transplantation.T-cell flow-cytometry crossmatch and long-term renal graft survival.De novo membranous nephropathy associated with donor-specific alloantibody.Predictive value of human leucocyte antigen epitope matching using HLAMatchmaker for graft outcomes in a predominantly African-American renal transplant cohort.Association of HLA phenotypes of end-stage renal disease patients preparing for first transplantation with anti-HLA antibody status.Pretransplantation monitoring of HLA antibodies by complement dependent cytotoxicity and Luminex-based assays.Bortezomib in ABO-incompatible kidney transplant desensitization: a case report.
P2860
Q28079184-A9DEEEDA-2CAD-4376-B855-10299BC0A321Q30315914-5435A5E5-CB84-4DA9-BEF1-A2CE149C9056Q30317554-F17870FE-039D-4255-AAB3-680A74701B02Q30317818-52356E57-F04F-4F29-A349-E928B56D69ACQ35094243-AEDDE9C2-3B07-4C17-92B1-631A3E678313Q35574072-3C2440B7-0971-4C10-8EE2-CE40728941F7Q36663036-2DC7A085-7D79-4AB8-8645-85FFF4D9FDF0Q37926524-ADB52530-55CA-4544-8ACA-63A7815BB5E7Q38017160-3B84A608-941D-451F-A376-9C951EE6A702Q38262909-051854CE-4026-4CE1-B7C3-E892609167BFQ40485532-DE75EC08-E5ED-4250-AF54-10AAD7CA4D5AQ46792984-EB1DCECE-8843-43F7-A447-55A19979225EQ46984237-72F9D387-C0AE-4E5D-9791-591C3DA10E20Q47860610-B268B77C-47A0-472F-8BE7-AA878B129761Q48300620-CAB51B33-696A-499C-85BB-D385955EB4E0Q50996014-E0EE4B8E-A036-4224-92B6-5ECE680D1B80
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
HLA-specific alloantibodies and renal graft outcome.
@ast
HLA-specific alloantibodies and renal graft outcome.
@en
HLA-specific alloantibodies and renal graft outcome.
@nl
type
label
HLA-specific alloantibodies and renal graft outcome.
@ast
HLA-specific alloantibodies and renal graft outcome.
@en
HLA-specific alloantibodies and renal graft outcome.
@nl
prefLabel
HLA-specific alloantibodies and renal graft outcome.
@ast
HLA-specific alloantibodies and renal graft outcome.
@en
HLA-specific alloantibodies and renal graft outcome.
@nl
P2860
P356
P1476
HLA-specific alloantibodies and renal graft outcome.
@en
P2093
Sumitran-Holgersson S
P2860
P304
P356
10.1093/NDT/16.5.897
P407
P577
2001-05-01T00:00:00Z